Adiponectin (*ADIPOQ*)^[@R1]--[@R4]^ is an anti-diabetic adipokine. Plasma adiponectin levels are reduced in obesity and type 2 diabetes^[@R5]^, while the replenishment of adiponectin reportedly ameliorated glucose intolerance and dyslipidemia in mice^[@R6]--[@R8]^. These beneficial effects of adiponectin are likely to be exerted, at least in part, by the activation of AMP-activated protein kinase (AMPK)^[@R9]--[@R11]^ and the peroxisome proliferator-activated receptor (PPAR)-α^[@R12],[@R13]^.

We previously reported the expression cloning of the complementary DNAs encoding adiponectin receptors 1 and 2 (*ADIPOR1* and *ADIPOR2*)^[@R14]^. AdipoR1 and AdipoR2 are predicted to contain a seven-transmembrane domain^[@R14]^, with an internal N-terminus and an external C-terminus, which is the opposite configuration to G-protein-coupled receptors (GPCRs). Therefore, AdipoR1 and AdipoR2 are thought to be structurally and functionally distinct from GPCRs^[@R15]^. AdipoR1 and AdipoR2 serve as the major receptors for adiponectin *in vivo*, with AdipoR1 activating the AMPK pathways and AdipoR2 activating the PPAR-α pathways such as increased expression of uncoupling protein 2 (UCP2)^[@R16]^. Thereby, they regulate glucose and lipid metabolism, inflammation, and oxidative stress *in vivo*. Recently, the small-molecule AdipoR agonist AdipoRon was shown to ameliorate diabetes and increase exercise endurance, and at the same time prolong the shortened lifespan in obesity^[@R17]^. It should also be noted that adiponectin receptors are conserved in evolution from mammals to plants and yeasts (<http://www.ncbi.nlm.nih.gov/>)^[@R18]^, strongly suggesting that they play essential biological roles.

It is extremely difficult to crystallize GPCRs, due to their conformational complexity. By achieving technical breakthroughs, Kobilka et al. successfully crystallized human β~2~ adrenoceptor (β~2~AR) and reported the crystal structures^[@R19]--[@R21]^. First, the conformational complexity of β~2~AR was controlled with high-affinity ligands (nanomolar dissociation constants), agonists and inverse agonists, to fix β~2~AR in the active and inactive forms, respectively^[@R20]--[@R23]^. Second, the crystallization was performed with antibody fragments and/or a protein fusion, in the lipidic mesophase. These technical advancements enabled the structure determination of many other GPCRs, and an understanding of their ligand specificities^[@R24]^. Furthermore, Kobilka et al. presented the first crystal structure of the active-state complex of an agonist-occupied β~2~AR with a nucleotide-free Gs heterotrimer^[@R25]^. Thus, the β~2~AR structures greatly impacted the fields of GPCR research and drug development^[@R26],[@R27]^.

In contrast to the GPCRs, no information is available about the conformational states of AdipoR1 and AdipoR2 with respect to transmembrane signaling. Although the AdipoR agonist AdipoRon was successfully developed^[@R17]^, further refinement of the AdipoR agonists to achieve nanomolar dissociation constants is still underway. The structural information about AdipoR1 and/or AdipoR2, if available, would be very important for understanding the AdipoR signaling mechanisms, and for developing and optimizing AdipoR agonists.

We optimized the properties of human AdipoR1 and AdipoR2 by deleting their N-terminal tails, and then used the Fv fragment of an anti-AdipoR monoclonal antibody and the lipidic mesophase for crystallization^[@R28]^. In this study, we successfully determined the crystal structures of human AdipoR1 and AdipoR2 at 2.9- and 2.4-Å resolution, respectively. The structures revealed their novel structural and functional properties, including the 7TM architecture, the zinc-binding site, and a putative adiponectin-binding surface, which are completely distinct from those of GPCRs, thus highlighting the uniqueness of the adiponectin receptors. This study should open new avenues toward the elucidation of an unprecedented paradigm of signal transduction and the development and optimization of AdipoR agonists.

Structure determinations of AdipoR1 and AdipoR2 in complexes with an Fv fragment {#S1}
================================================================================

The N-terminally truncated constructs of human AdipoR1 and AdipoR2 (residues 89--375 and 100--386, respectively) exhibited better expression and purification properties than the full-length proteins^[@R28]^. These N-terminally-truncated AdipoR1 and AdipoR2 displayed the same extents of adiponectin-stimulated AMPK phosphorylation^[@R9]--[@R11]^ ([Extended Data Fig. 1a](#F6){ref-type="fig"}) and *UCP2* upregulation^[@R12],[@R13]^ ([Extended Data Fig. 1b](#F6){ref-type="fig"}), respectively, as those of the full-length proteins. Therefore, the N-terminally-truncated AdipoR proteins were crystallized with the Fv fragment of a monoclonal antibody that recognizes a conformational epitope of both AdipoR1 and AdipoR2 in a cholesterol-doped monoolein lipidic mesophase^[@R28]^. Thus, we determined the crystal structures of AdipoR1 ([Fig. 1a](#F1){ref-type="fig"}, [Extended Data Fig. 1c--e](#F6){ref-type="fig"}) and AdipoR2 ([Fig. 1b](#F1){ref-type="fig"}, [Extended Data Fig. 1f--h](#F6){ref-type="fig"}) at 2.9- and 2.4-Å resolution, respectively. Data collection and refinement statistics are provided in [Extended Data Table 1](#T1){ref-type="table"}.

Overall structures of the AdipoR1•Fv and AdipoR2•Fv complexes {#S2}
=============================================================

The AdipoR1 protein (residues 89--375) contains the N-terminal intracellular region (residues 89--120, NTR), a short intracellular helix (residues 121--129, helix 0), the 7TM domain (residues 134--364), and the C-terminal extracellular region (residues 365--375, CTR) ([Figs. 1a](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The Fv fragment is bound to the NTR ([Extended Data Fig. 2a](#F7){ref-type="fig"}). The seven transmembrane helices (I--VII) are formed by residues 135--157, 169--192, 198--227, 232--252, 264--288, 305--319, and 336--364, respectively, and are connected by three intracellular loops (ICL1--3) and three extracellular loops (ECL1--3). ECL3 has a short α helix (residues 291--295, the ECL helix) in its center, while ICL3 has another short α helix (residues 322--325, the ICL helix) just after helix VI. All of the residues are structurally ordered, except for residues 159--160 in ECL1, residues 298--299 in ECL3, and residues 374--375 in the CTR.

The seven transmembrane helices of AdipoR1 form a helix bundle. As viewed from the outside of the cell, the seven transmembrane helices in the helix bundle are arranged circularly in a clockwise manner, from helix I to helix VII ([Fig. 1a](#F1){ref-type="fig"}). The structure of AdipoR2 is quite similar to that of AdipoR1 ([Fig. 1](#F1){ref-type="fig"}, [Extended Data Fig. 2a--c](#F7){ref-type="fig"}). The r.m.s.d. value for the main-chain Cα atoms between the AdipoR1 and AdipoR2 structures is as small as 0.56 Å.

The DALI search^[@R29]^ indicated that the AdipoR1 and AdipoR2 structures share no similarity with other protein structures in the Protein Data Bank. The C-terminus-out topology of the 7TM domain of AdipoR1/AdipoR2, relative to the plasma membrane, is opposite to the N-terminus-out topology of the conventional 7TM proteins, such as GPCRs^[@R30]^ and microbial rhodopsins^[@R31]^. Furthermore, the conformational characteristics, such as the proline-induced kink^[@R19]--[@R21]^, of the transmembrane helices of GPCRs in classes A, B, and C^[@R20],[@R21],[@R32],[@R33]^ are not observed for those of AdipoR1/AdipoR2 ([Extended Data Fig. 3](#F8){ref-type="fig"}). In the AdipoR1/AdipoR2 structures, the transmembrane helices are not kinked, while helix V is slightly curved due to three Gly residues ([Fig. 2](#F2){ref-type="fig"}). Consequently, we concluded that the AdipoR1 and AdipoR2 structures are novel.

The zinc-binding sites of AdipoR1 and AdipoR2 {#S3}
=============================================

Remarkably, we found a zinc ion bound within the 7TM domain in the AdipoR1 and AdipoR2 structures ([Fig. 3a](#F3){ref-type="fig"}), by X-ray absorption spectroscopy (data not shown) and the anomalous difference Fourier map ([Fig. 3b](#F3){ref-type="fig"}). The zinc-binding site is located in the intracellular layer of the membrane. The zinc ion is coordinated by three His residues, H191 in helix II and H337 and H341 in helix VII of AdipoR1 and H202 in helix II and H348 and H352 in helix VII of AdipoR2, at zinc--nitrogen distances of 2.1--2.6 Å ([Fig. 3c, d](#F3){ref-type="fig"}). The zinc ion is thus located approximately 4 Å deep from the inner surface of the plasma membrane ([Fig. 3a](#F3){ref-type="fig"}). Furthermore, a water molecule is observed between the zinc ion and the side-chain carboxyl group of D219 in helix III of AdipoR2. Thus, the zinc ion has a tetrahedral coordination ([Fig. 3d](#F3){ref-type="fig"}). The zinc ion binds helices II, III, and VII together ([Fig. 3c, d](#F3){ref-type="fig"}), and probably stabilizes the structure of the subdomain consisting of helices I, II, III, and VII ([Extended Data Fig. 2](#F7){ref-type="fig"}). The 3×His and Asp residues of AdipoR1 and AdipoR2 are strictly conserved in the homologues from mammals to plants and bacteria ([Extended Data Fig. 4a, b](#F9){ref-type="fig"}).

We mutated the zinc-coordinated 3×His and Asp residues of AdipoR1 (residues 89--375) ([Fig. 3e](#F3){ref-type="fig"}). As compared with the parent AdipoR1 molecule (89--375), the adiponectin-stimulated AMPK phosphorylation was reduced by the triple mutant H191A/H337A/H341A (3A) and more seriously by the quadruple mutant H191A/D208A/H337A/H341A (4A), while none of the single H191A, D208A, H337A, and H341A mutations affected it ([Fig. 3e](#F3){ref-type="fig"}, [Extended Data Fig. 4c](#F9){ref-type="fig"}). Therefore, the results suggested that zinc binding is not directly required for the adiponectin-stimulated AMPK phosphorylation, but exerts a putative structure-stabilizing effect.

In contrast, the adiponectin-stimulated *UCP2* upregulation by AdipoR2 was drastically reduced by each of the single mutations D219A and H348A, and nearly completely eliminated by the triple mutation H202A/H348A/H352A (3A) and the quadruple mutation H202A/D219/H348A/H352A (4A) of AdipoR2 (residues 1--386 and 100--386), as compared with the wild-type AdipoR2 ([Fig. 3f](#F3){ref-type="fig"}, [Extended Data Fig. 4d, e](#F9){ref-type="fig"}). Correspondingly, the single mutations H202A and H352A of AdipoR2 (residues 100--386) did not decrease the amount of bound zinc ion, whereas the single mutations D219A and H348A decreased it moderately, and the multiple mutations 3A and 4A reduced it drastically (data not shown). These results suggested that the zinc ion is directly involved in the adiponectin-stimulated *UCP2* upregulation in the case of AdipoR2, in addition to structural stabilization.

An attractive hypothesis is that AdipoR2 has zinc-ion-dependent hydrolytic activity, and uses the water molecule fixed between the zinc ion and the side-chain carboxyl group of D219 of AdipoR2 for the nucleophilic attack on the carbonyl carbon atom of substrates. Free fatty acid (FFA) might be produced from lipid hydrolysis by the adiponectin-stimulated AdipoR2, and PPARα activation by the produced FFA would increase the expression of the target genes, such as *UCP2*.

The zinc-binding structures in the transmembrane domains of AdipoR1 and AdipoR2 are novel. The only previously reported membrane protein structure with a zinc ion within the transmembrane domain is that of a site-2 protease family intramembrane metalloprotease^[@R34]^. The protease consists of six transmembrane segments, and the catalytic zinc ion is coordinated by two His residues and one Asp residue, and is approximately 14 Å deep from the inner surface of the plasma membrane. Therefore, the structural features of the two proteins are not homologous. By contrast, some globular zinc enzyme structures share architectural similarity, in terms of the coordination of three His residues and a water molecule^[@R35],[@R36]^ ([Extended Data Fig. 5](#F10){ref-type="fig"}). Although the transmembrane alkaline ceramidases share negligible sequence homology with AdipoR, a set of 3×His and Asp residues is conserved in these proteins. However, their crystal structures have not been solved. Therefore, we presently cannot completely exclude the possibility that the AdipoRs have ceramidase activity.

The large internal cavities of AdipoR1 and AdipoR2 {#S4}
==================================================

In both the AdipoR1 and AdipoR2 structures, the seven transmembrane helices surround a large internal cavity, including the zinc-binding site ([Fig. 4a, b](#F4){ref-type="fig"}). This large internal cavity is formed between the four- and three-helix subdomains (helices VII-I-II-III and IV-V-VI, respectively) of the 7TM domains of AdipoR1/2 ([Extended Data Fig. 2](#F7){ref-type="fig"}). The cavities extend from the cytoplasmic surface to the middle of the outer lipid layer of the membrane ([Fig. 4a, b](#F4){ref-type="fig"}), and contain unidentified extra electron densities, which are weaker than those of the protein ([Fig. 4c, d](#F4){ref-type="fig"}). In the cavity of AdipoR2, the extra electron densities are observed along with helices III, V, and VI ([Fig. 4d](#F4){ref-type="fig"}). In contrast, in the cavity of AdipoR1, even weaker electron densities are observed on the cytoplasmic side of the cavity ([Fig. 4c](#F4){ref-type="fig"}). These weak electron densities might be relevant to the substrates/products of the hypothesized hydrolytic activities of AdipoR1/AdipoR2.

The cavity has small openings between helices V and VI within the outer lipid layer and between helices IV and VI on the cytoplasmic side ([Fig. 4a, b](#F4){ref-type="fig"}). Intriguingly, a much larger opening at helices III--VII would be uncovered on the cytoplasmic side, if the NTR was displaced from its present position ([Extended Data Fig. 6](#F11){ref-type="fig"}). These openings might serve as the entrance/exit for the substrate/product of the hypothesized hydrolytic activity. Intriguingly, the shorter constructs (residues 102--375 and 120--375) of AdipoR1 are also as active as the full-length AdipoR1 with respect to adiponectin-stimulated AMPK phosphorylation ([Extended Data Fig. 1a](#F6){ref-type="fig"}), indicating that the NTR, which covers the large internal cavity, is not required for this activity.

The amino acid sequences of the ICL2 regions are significantly different between AdipoR1 and AdipoR2 ([Fig. 2](#F2){ref-type="fig"}). In particular, AdipoR1 has a cluster of positively charged residues, Arg257, Lys262, and His263, in the ICL2 region ([Extended Data Fig. 7](#F12){ref-type="fig"}), unlike AdipoR2. Consequently, this structural difference in the cytoplasmic face may reflect the distinct signaling pathways downstream of these adiponectin receptors.

The extracellular faces of AdipoR1 and AdipoR2 {#S5}
==============================================

The ECL1--3 and the CTR are exposed on the extracellular faces of AdipoR1 and AdipoR2. The three extracellular loops exhibit high conservation between AdipoR1 and AdipoR2 ([Fig. 5a--d](#F5){ref-type="fig"}). Helices VII and III are longer than the others, and the C-terminal two turns of helix VII protrude from the extracellular face. The CTR, which follows helix VII, seems to be independent of the other extracellular structural elements, the ECL1--3 and helix VII ([Fig. 1](#F1){ref-type="fig"}). The very C-terminal L374--L375 (AdipoR1) and A385--L386 (AdipoR2) residues are disordered, and the crystal packing fixed the tail conformations differently ([Extended Data Fig. 8](#F13){ref-type="fig"}). Therefore, the entire CTRs of AdipoR1 and AdipoR2 are likely to be flexible and unstructured ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

Adiponectin should bind to the extracellular face of the receptor, and the adiponectin-binding site seems to be shared by AdipoR1 and AdipoR2. A yeast two-hybrid analysis revealed that the C-terminal fragment, which extends from the middle of helix VI to the very C-terminus, as determined by the present structures, interacts with adiponectin^[@R37]^. Therefore, adiponectin might bind to the CTR of AdipoR1/2. However, in this study, the deletion of the CTR (AdipoR1 residues 1--370 and 1--366) did not affect the adiponectin-stimulated AMPK phosphorylation via AdipoR1 ([Fig. 5e](#F5){ref-type="fig"}), indicating that the flexible CTR is not necessarily required for AMPK phosphorylation by adiponectin. By contrast, the deletion of the C-terminal thirteen residues, which include the last two residues of helix VII, Y363--G364, reduced the adiponectin-stimulated AMPK phosphorylation via AdipoR1 (residues 1--362, [Fig. 5e](#F5){ref-type="fig"}, [Extended Data Fig. 9a](#F14){ref-type="fig"}), indicating that the protruding C-terminal turn of helix VII may be involved in adiponectin signaling. Furthermore, the extracellular loop residues conserved between AdipoR1 and AdipoR2 were mutated to Gly/Ser ([Fig. 5f, g](#F5){ref-type="fig"}): the three-loop mutation (ECL1/2/3) combined with the C-terminal thirteen-residue deletion (1--362), the 1--362/ECL1/2/3 mutation, remarkably decreased adiponectin-stimulated AMPK phosphorylation via AdipoR1 ([Fig. 5g](#F5){ref-type="fig"}, [Extended Data Fig. 9b](#F14){ref-type="fig"}). The other mutants with fewer Gly/Ser mutations (ECL1, ECL2, ECL3, and ECL1/3) or with no C-terminal deletion showed correspondingly smaller decreased ([Fig. 5f, g](#F5){ref-type="fig"}, [Extended Data Fig. 9a, b](#F14){ref-type="fig"}). These data raised the possibility that AdipoR1 may recognize adiponectin by the extensive use of its extracellular face, including the three extracellular loops and the C-terminal turns of helix VII.

Conclusions {#S6}
===========

The structural and functional characteristics of AdipoR1 and AdipoR2 revealed by this study are completely different from those of GPCRs, and therefore the AdipoRs represent an entirely novel class of receptor. The present crystal structures are expected to provide a strong basis for the development and optimization of adiponectin receptor agonists, such as AdipoRon^[@R17]^, as well as for understanding the roles and mechanisms of the AdipoR1/AdipoR2 homologues from animals and plants in putative signaling, such as in defense systems and lipid metabolism ([Extended Data Fig. 4a, b](#F9){ref-type="fig"}).

METHODS {#S7}
=======

Preparation of the AdipoR1•Fv and AdipoR2•Fv crystals {#S8}
-----------------------------------------------------

The human AdipoR1 and AdipoR2 proteins and the Fv fragment of an anti-AdipoR1 monoclonal antibody were prepared as described^[@R28]^. In brief, human AdipoR1 and AdipoR2 (residues 89--375 and 100--386, respectively) were expressed in High Five insect cells. The proteins were purified by Flag antibody affinity chromatography followed by anion exchange chromatography, metal ion affinity chromatography after cleaving the N-terminal Flag tag by His-tagged tobacco etch virus (TEV) protease, and size-exclusion chromatography. The Fv fragment was cloned from hybridoma cells. The Fv fragment was synthesized by the *E. coli* cell-free protein synthesis method, and purified by Ni-affinity chromatography followed by size-exclusion chromatography. The purified AdipoR1 and AdipoR2 proteins were mixed with the Fv fragment, and the AdipoR1•Fv and AdipoR2•Fv complexes were purified by size-exclusion chromatography, and were crystallized by the lipidic mesophase method^[@R38]^.

X-ray data collection {#S9}
---------------------

Data collection was performed on beamline BL32XU at SPring-8, using an MX225HE CCD detector^[@R39]--[@R41]^. X-ray diffraction data were collected at 100 K by the helical scan method, with a beam size of 1 × 10 μm (horizontal × vertical) using 1° oscillation. The AdipoR1 and AdipoR2 crystals diffracted up to 2.8-Å and 2.2-Å resolution, respectively^[@R28]^. Data collection from the AdipoR1 crystals was limited to 10--30 images per crystal, due to radiation damage in the microcrystals, and data from 5 crystals were merged to complete the data set. For AdipoR2, diffraction data were collected from a single crystal. The data from the AdipoR1 crystals and the AdipoR2 crystal were indexed, scaled, and merged with the HKL2000 program suite^[@R42]^ and the XDS package^[@R43]^, respectively. The data collection statistics are shown in [Extended Data Table 1](#T1){ref-type="table"}. The AdipoR1 crystals belonged to the space group *C*222~1~, with unit cell parameters *a* = 92.3, *b* = 194.1, *c* = 74.3 Å, and the AdipoR2 crystal belonged to the space group *P*2~1~2~1~2, with unit cell parameters *a* = 74.6, *b* = 108.6, *c* = 101.0 Å.

Structure solution and refinement {#S10}
---------------------------------

The initial phases for the AdipoR2•Fv complex were obtained by molecular replacement, using Fv (the V~H~ and V~L~ fragments from PDB IDs 1E6J and 1FDL, respectively) in Phaser^[@R44]^ as a search model. The resulting phases were improved by density modification using the program RESOLVE^[@R45]^, and thereby the electron density map around the helix bundle region of AdipoR2 became clearly visible. The initial model (all of Fv and about 80% of AdipoR2) was automatically built using the program AutoBuild^[@R46]^, and the rest of the model (the loops connecting the transmembrane helices) was built manually using COOT^[@R47]^. Refinement was performed with phenix.refine^[@R48]^, and the refined coordinates were rebuilt with COOT. The structure of the AdipoR2•Fv complex was refined with final R/R~free~ values of 0.25/0.29. The structure of the AdipoR1•Fv complex was determined by molecular replacement, using that of the AdipoR2•Fv complex as a search model, and was refined with the secondary structure restraints in phenix.refine. Refinement of the AdipoR1•Fv complex was performed similarly to that of the AdipoR2•Fv complex. The structure of the AdipoR1•Fv complex was refined with final R/R~free~ values of 0.24/0.30. Each of the final models of the AdipoR1•Fv and AdipoR2•Fv complexes includes 281 residues of the receptor, 119 residues of V~H~, and 107 residues of V~L~. The data collection and refinement statistics are summarized in [Extended Data Table 1](#T1){ref-type="table"}. Structural illustrations were generated using PyMol^[@R49]^.

Cell culture {#S11}
------------

HEK293T cells (ATCC) were cultured in DMEM supplemented with 10% (v/v) fetal bovine serum. Cells were transfected by using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. The cDNAs encoding the AdipoR mutants were introduced into the pOriP vector, for the expression of proteins tagged with a Flag epitope.

Generation of recombinant adiponectin {#S12}
-------------------------------------

Recombinant mouse full-length adiponectin was generated as previously described^[@R6],[@R9],[@R13],[@R14],[@R17],[@R50]^. The expression of histidine-tagged adiponectin was induced by the addition of isopropyl β-D-1-thiogalactopyranoside to the growth medium. Bacterial extracts were prepared using standard methods, and the fusion proteins were purified by elution through a nickel-ion agarose column.

Western blot analysis and measurement of AMPK activities {#S13}
--------------------------------------------------------

Phosphorylation and protein levels of αAMPK were determined as described^[@R51]--[@R54]^. Western blot analyses were performed with anti-phosphorylated-AMPK (Cell Signaling Technology \#2535) and anti-αAMPK (Cell Signaling Technology \#2532) antibodies. Protein levels of AdipoR were analyzed by western blotting, using an anti-Flag antibody (Sigma-Aldrich F1804).

Real-time PCR {#S14}
-------------

Real-time PCR was performed according to the method described previously^[@R16],[@R50]^. Total RNA was prepared from cells with Trizol (Invitrogen), according to the manufacturer's instructions. We used the real-time PCR method to quantify the mRNAs^[@R14]^, with slight modifications.

Extended Data {#S15}
=============

![Analysis of N-terminal deletion mutants of AdipoR1 and AdipoR2 and lattice packing of the AdipoR1•Fv and AdipoR2•Fv crystals\
**a**, Phosphorylation and amounts of AMPK in HEK293 cells transfected with full-length AdipoR1 (residues 1--375) or N-terminally truncated mutants (residues 47--375, 77--375, 89--375, 102--375, and 120--375), treated for 5 min with adiponectin (15 μg ml^−1^). **b**, *UCP2* mRNA levels in HEK293 cells transfected with full-length AdipoR2 (residues 1--386) or N-terminally truncated mutants (residues 88--386 and 100--386), treated for 18 hr with adiponectin (3 μg ml^−1^). All values are presented as mean ± s.e.m., *n* = 3--4, and \*\**P* \< 0.01 compared to control cells or as indicated. NS, not significant. **c--h,** Lattice packing of the AdipoR1•Fv crystals (**c--e**) and the AdipoR2•Fv crystals (**f--h**). AdipoR1, AdipoR2, and Fv are colored green, cyan, and grey, respectively. The AdipoR1•Fv and AdipoR2•Fv complexes crystallized with an anti-parallel arrangement of the receptor molecules.](emss-62152-f0006){#F6}

![Comparison of the AdipoR1•Fv and AdipoR2•Fv structures\
**a--c,** Superimposition of the AdipoR1•Fv and AdipoR2•Fv complexes: side view (**a**), extracellular view (**b**), intracellular view (**c**). Fv was omitted from the intracellular view for clarity. **d,** Superimposition of the subdomains consisting of helices I, II, III, and VII between AdipoR1 and AdipoR2. The Cα r.m.s.d. value is 0.34 Å. **e,** Helix 0 (pink) interacts hydrophobically with the cytoplasmic ends of helices I--III, and the ICL1 (purple), as represented by those of AdipoR1. In addition, the zinc ion firmly connects helices VII, II, and III ([Fig. 3](#F3){ref-type="fig"}). Therefore, helices VII, I, II, and III (**d**) constitute a rigid subdomain in the 7TM-domain structures. In contrast, helices IV, V, and VI are superimposed between AdipoR1 and AdipoR2 with a Cα r.m.s.d. value of 0.73 Å, and are likely to constitute the other subdomain, with some conformational differences in helix V between AdipoR1 and AdipoR2.](emss-62152-f0007){#F7}

![Comparison of the AdipoR2 structure with other 7TM proteins\
Superimpositions of AdipoR2 (cyan) with the β~2~AR (PDB ID 2RH1) (r.m.s.d. 3.9 Å) (**a**), the glucagon receptor (PDB ID 4L6R) (r.m.s.d. 3.8 Å) (**b**), the metabotropic glutamate receptor 1 (PDB ID 4OR2) (r.m.s.d. 2.9 Å) (**c**)**,** the sphingosine 1-phosphate receptor 1 (PDB ID 3V2Y)^[@R55]^ (r.m.s.d. 3.0 Å) (**d**), the A~2A~ adenosine receptor (PDB ID 2YDV)^[@R56]^ (r.m.s.d. 3.4 Å) (**e**), and sensory rhodopsin (PDB ID 1XIO)^[@R57]^ (r.m.s.d. 3.1 Å) (**f**) in orange. The AdipoR2 and other 7TM protein structures are viewed parallel to the membrane (top) and from the extracellular and intracellular sides, respectively (bottom).](emss-62152-f0008){#F8}

![The zinc-binding sites of AdipoR1 and AdipoR2\
**a, b,** The zinc-binding sites of AdipoR1 (**a**) and AdipoR2 (**b**) are conserved from mammals to plants. The conserved residues, the 3×His and Asp residues and a Ser residue, are shown in red. The side chains of S187 (AdipoR1) and S198 (AdipoR2) in helix II are located 3.7 and 3.8 Å, respectively, away from the zinc ion (data not shown and [Fig. 3b](#F3){ref-type="fig"}). **c, d,** The amounts of AdipoR1 (**c**) and AdipoR2 (**d**) in HEK293 cells transfected with AdipoR1 (residues 89--375), AdipoR2 (residues 100--386) or a variety of mutants of AdipoR1 and AdipoR2 were analyzed by western blotting, using an anti-Flag antibody. The label 89--375 indicates no mutation, and the other labels, such as H191A and 4A, indicate the single and multiple mutations (see text). The label 100--386 indicates no mutation, and the other labels, such as H202A and 4A, indicate the single and multiple mutations (see text). **e,** *UCP2* mRNA levels in HEK293 cells transfected with full-length AdipoR2 (residues 1--386) or a zinc-binding site mutant. All values are presented as mean ± s.e.m., *n* = 3--4, \**P* \< 0.05, and \*\**P* \< 0.01 compared to control cells or as indicated.](emss-62152-f0009){#F9}

![The zinc-binding sites of soluble proteins\
**a, b,** The zinc-binding sites of *Astacus astacus L.* astacin (PDB ID 1AST) (**a**) and human carbonic anhydrase II (PDB ID 1CA2) (**b**). The zinc ion (magenta) is coordinated by three His residues and a water molecule (pink sphere).](emss-62152-f0010){#F10}

![The cytoplasmic side of AdipoR1\
**a, b,** Structures of AdipoR1 residues 89--375 (**a**) and 120--375 (**b**) viewed parallel to the membrane. **c, d,** The cavity of AdipoR1 \[residues 89--375 (**c**) and 120--375 (**d**)\] viewed from the cytoplasmic side. Residues 120--375, including helix 0, the 7TM domain, and the CTR, are colored green. The NTR (residues 89--119) is colored orange.](emss-62152-f0011){#F11}

![The cytoplasmic faces of AdipoR2 and AdipoR1\
**a, b,** Intracellular views of AdipoR1 (**a**) and AdipoR2 (**b**). The openings of the cavities are circled in red. The N-terminal regions of the AdipoRs are represented as surface models (orange). **c, d,** The ICL2s of AdipoR1 (**c**) and AdipoR2 (**d**).](emss-62152-f0012){#F12}

![Crystal packing of the CTRs of AdipoR1 and AdipoR2\
Crystal packing of the CTR of AdipoR1 with Fv (**a**) and the CTR of AdipoR2 with Fv (**b**). The CTR of AdipoR1 is tucked between the two Fv fragments, whereas the C-terminal tail of AdipoR2 contacts the framework region 1 of V~H~ (orange). The CTRs are colored purple.](emss-62152-f0013){#F13}

![Expression of the AdipoR1 mutant proteins\
The amounts of AdipoR1 in HEK293 cells transfected with full-length AdipoR1 (residues 1--375) or a variety of mutants of AdipoR1 were analyzed by western blotting, using an anti-Flag antibody. Full-length AdipoR1 (residues 1--375) and the C-terminally truncated mutant (residues 1--370, 1--366, and 1--362) were used in (**a**). AdipoR1 residues 1--375, MYFMAPL (residues 161--167) changed to SGSSGGS (ECL1); residues 1--375, YCS (residues 229--231) changed to GGG (ECL2); residues 1--375, FVKATTV (residues 291--297) changed to SSSGGGS (ECL3); residues 1--375, ECL1 and ECL3 (ECL1/3); and residues 1--375, ECL1, ECL2 and ECL3 (ECL1/2/3) were used in (**b**).](emss-62152-f0014){#F14}

###### X-ray data collection and refinement statistics.

  Structure                            AdipoR1•Fv complex                                     AdipoR2•Fv complex
  ------------------------------------ ------------------------------------------------------ ----------------------
  **Data collection**                                                                         
  No. of crystals                      5                                                      1
  X-ray source                         BL32XU, SPring-8                                       BL32XU, SPring-8
  Wavelength (Å)                       1                                                      1
  Space group                          *C*222~1~                                              *P*2~1~2~1~2
  Cell dimensions                                                                             
   *a, b, c* (Å)                       92.3, 194.1, 74.3                                      74.6, 108.6, 101.0
   *α, β, γ* (°)                       90.0, 90.0, 90.0                                       90.0, 90.0, 90.0
  No. of reflections measured          112167                                                 145165
  No. of unique reflections            15105                                                  32174
  Resolution (Å)                       20.0--2.9 (3.0--2.9)[\*](#TFN1){ref-type="table-fn"}   19.5--2.4 (2.5--2.4)
  *R* ~merge~                          0.192 (0.930)                                          0.115 (1.297)
  Mean *I*/s(*I*)                      6.73 (2.03)                                            8.55 (1.19)
  Completeness (%)                     99.7 (100.0)                                           98.3 (99.4)
  Redundancy                           7.4 (7.5)                                              4.5 (4.5)
  **Refinement**                                                                              
  Resolution (Å)                       19.9--2.9                                              19.5--2.4
  No. of unique reflections            15098                                                  32141
  *R*~work~ / *R*~free~ (%)            23.9 / 30.0                                            24.8 / 29.0
  CC1/2                                0.976 (0.517)                                          0.966 (0.506)
  CC[\*](#TFN1){ref-type="table-fn"}   0.994 (0.826)                                          0.999 (0.820)
  Number of atoms                                                                             
   AdipoR                              2294                                                   2286
   Fv                                  1747                                                   1747
   Zn                                  1                                                      1
   water                               \-                                                     52
  Average B-factors (Å^2^)                                                                    
   overall                             62.1                                                   66.3
   Protein                             62.1                                                   66.4
   Zn                                  49.5                                                   56.3
   water                               \-                                                     61.5
  R.m.s. deviations                                                                           
   Bond lengths (Å)                    0.004                                                  0.003
   Bond angles (°)                     0.81                                                   0.76
  Ramachandran plot (%)                                                                       
   Favored region                      95.8                                                   95.6
   Allowed region                      4.2                                                    4.4
   Outlier region                      0                                                      0

Highest resolution shell is shown in parentheses
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![Overall structures of AdipoR1 and AdipoR2\
**a**, The 2.9-Å resolution structure of AdipoR1. **b,** The 2.4-Å resolution structure of AdipoR2. The structures were determined for their complexes with an Fv fragment, but the Fv fragments are omitted here for clarity. The structures are viewed from the extracellular side (left) and parallel to the membrane (right). The NTR, helix 0, transmembrane helices I--VII, and the CTR of AdipoR1 (**a**) and AdipoR2 (**b**) are indicated.](emss-62152-f0001){#F1}

![Sequence alignment of human AdipoR1 and AdipoR2\
Amino acid residues that are not conserved between these receptors are shown in green (AdipoR1) and cyan (AdipoR2). The deleted residues in the constructs and the disordered residues in the crystal structures are shown in grey and yellow, respectively. The helices in the crystal structures are surrounded with blue squares. The identical and similar residues between the two proteins are indicated with red asterisks and black colons, respectively. The Gly residues in helix V and in the CTR are indicated with red and blue number signs, respectively.](emss-62152-f0002){#F2}

![The zinc-binding sites of AdipoR1 and AdipoR2\
**a,** The position of the zinc ion (magenta sphere) in the AdipoR2 structure. **b,** The anomalous difference maps of AdipoR2 calculated from the peak data set (red, 1.28 Å) and the low remote data set (blue, 1.288 Å), at a resolution of 3.0 Å and contoured at 3.0 σ. Helix I has been omitted for clarity. **c, d,** Coordination of the zinc ion (magenta sphere) by three His residues of AdipoR1 (**c**) and AdipoR2 (**d**), viewed from the cytoplasmic side. A water molecule (pink sphere) is also coordinated to the zinc ion, and is fixed by D219 in AdipoR2. **e,** Phosphorylation and amounts of AMPK in HEK293 cells transfected with AdipoR1 (residues 89--375) or its mutants (see text), treated for 5 min with adiponectin (15 μg ml^−1^). **f,** *UCP2* mRNA levels in HEK293 cells transfected with AdipoR2 (residues 100--386) or its mutants (see text), treated for 18 hr with adiponectin (3 μg ml^−1^). All values are presented as mean ± s.e.m., *n* = 3--4, \**P* \< 0.05, and \*\**P* \< 0.01 compared to control cells or as indicated. Ad, adiponectin.](emss-62152-f0003){#F3}

![The large internal cavities in the AdipoR1 and AdipoR2 structures\
**a, b,** The cavities of AdipoR1 (**a**) and AdipoR2 (**b**). The red arrows indicate the openings of the cavities. **c, d,** The extra electron density maps in the cavities of AdipoR1 (**c**) and AdipoR2 (**d**) contoured at 0.5 σ and 1 σ, respectively. The NTR (residues 89--119) is colored orange. The openings of the cavities are bordered in red.](emss-62152-f0004){#F4}

![The extracellular faces of AdipoR1 and AdipoR2\
**a--d,** The extracellular faces of AdipoR1 (**a**, **b**) and AdipoR2 (**c**, **d**). AdipoR1 and AdipoR2 are shown by surface (**a**, **c**) and cartoon (**b**, **d**) representations. The residues conserved between AdipoR1 and AdipoR2 are shown in red and labeled in black. The AdipoR1- and AdipoR2-specific residues are shown in green and cyan, respectively. The 7TM domains of AdipoR1 and AdipoR2 are shown in grey. The CTR residues ^370^TDD^372^ and ^381^EED^383^ of AdipoR1 and AdipoR2, respectively, were removed for clarity. **e--g,** Phosphorylation and amounts of AMPK in HEK293 cells transfected with full-length AdipoR1 (residues 1--375) or a variety of mutants of AdipoR1, treated for 5 min with adiponectin (15 μg ml^−1^). All values are presented as mean ± s.e.m., *n* = 3--4, \**P* \< 0.05, and \*\**P* \< 0.01 compared to control cells or as indicated. Ad, adiponectin; ECL1, ^161^MYFMAPL^167^→SGSSGGS; ECL2, ^229^YCS^231^→GGG; ECL3, ^291^FVKATTV^297^→SSSGGGS; ECL1/3, ECL1+ECL3; ECL1/2/3, ECL1+ECL2+ECL3.](emss-62152-f0005){#F5}
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